Difference between revisions of "ICRP Glossary"
| Line 45: | Line 45: | ||
*[[Acute Exposure]] | *[[Acute Exposure]] | ||
| − | *[[Acute radiation syndrome] | + | *[[Acute radiation syndrome]] |
| + | |||
| + | *[[Adaptive response]] | ||
| + | |||
| + | *[[Additive risk projection model]] | ||
*[[Adventitious]] | *[[Adventitious]] | ||
| Line 78: | Line 82: | ||
*[[Area monitoring]] | *[[Area monitoring]] | ||
| + | |||
| + | *[[Attributable risk]] | ||
*[[Auger transition]] | *[[Auger transition]] | ||
| Line 100: | Line 106: | ||
*[[Basal cell]] | *[[Basal cell]] | ||
| + | |||
| + | *[[Baseline disease rates]] | ||
*[[Beneficence]] | *[[Beneficence]] | ||
| Line 112: | Line 120: | ||
*[[Bioassay]] | *[[Bioassay]] | ||
| + | |||
| + | *[[Biomarker]] | ||
*[[Biomedical research volunteer]] | *[[Biomedical research volunteer]] | ||
| Line 136: | Line 146: | ||
*[[Cardioverter-defibrillator]] | *[[Cardioverter-defibrillator]] | ||
| + | |||
| + | *[[Case–control study]] | ||
*[[Cell death]] | *[[Cell death]] | ||
| Line 154: | Line 166: | ||
*[[Co-expertise]] | *[[Co-expertise]] | ||
| + | |||
| + | *[[Cohort study]] | ||
*[[Colony]] | *[[Colony]] | ||
| Line 194: | Line 208: | ||
*[[Deontological Ethics]] | *[[Deontological Ethics]] | ||
| + | |||
| + | *[[Deterministic effect]] | ||
| + | |||
| + | *[[Detriment]] | ||
| + | |||
| + | *[[Detriment-adjusted risk]] | ||
*[[Diastasis]] | *[[Diastasis]] | ||
| + | |||
| + | *[[Dicentric chromosome]] | ||
*[[Dichotomous]] | *[[Dichotomous]] | ||
| Line 210: | Line 232: | ||
*[[DNA damage signalling]] | *[[DNA damage signalling]] | ||
| + | |||
| + | *[[Dose and dose-rate effectiveness factor (DDREF)]] | ||
*[[Dose constraint]] | *[[Dose constraint]] | ||
| Line 226: | Line 250: | ||
*[[Dose rate effectiveness factor]] | *[[Dose rate effectiveness factor]] | ||
| + | |||
| + | *[[Dose-threshold hypothesis]] | ||
*[[Dose-rate effect]] | *[[Dose-rate effect]] | ||
| Line 232: | Line 258: | ||
*[[Dose-threshold]] | *[[Dose-threshold]] | ||
| + | |||
| + | *[[Doubling dose]] | ||
=== <big><span id="E">E</span></big> === | === <big><span id="E">E</span></big> === | ||
Revision as of 19:58, 24 February 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. It is a living document, updated regularly. Each entry shows the date it was last updated, and some include past glossary entries to help readers better understand the term in a particular context.
Many ICRP publications have included their own glossaries. The ICRP Glossary includes most of the terms in these other glossaries, many with updated entries. ICRP publications will continue to have their own glossaries when necessary, for example for highly specialized terms relevant to a single publication or helpful for a reader to have close at hand, or when introducing a new term which would also be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being prepared, and will be added here in due course.
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
